How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort.
about
Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factorsClinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines.A vitamin D receptor agonist converts CD4+ T cells to Foxp3+ regulatory T cells in patients with ulcerative colitis.Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
P2860
How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
How fast up the ladder? Factor ...... rom a population-based cohort.
@en
How fast up the ladder? Factor ...... rom a population-based cohort.
@nl
type
label
How fast up the ladder? Factor ...... rom a population-based cohort.
@en
How fast up the ladder? Factor ...... rom a population-based cohort.
@nl
prefLabel
How fast up the ladder? Factor ...... rom a population-based cohort.
@en
How fast up the ladder? Factor ...... rom a population-based cohort.
@nl
P2093
P2860
P1476
How fast up the ladder? Factor ...... rom a population-based cohort.
@en
P2093
Angela Takses
Bernd Salzberger
Claudia Ott
Elisabeth Schnoy
Florian Obermeier
Martina Müller
P2860
P2888
P304
P356
10.1007/S00384-014-2002-Z
P577
2014-09-03T00:00:00Z